Turtle Creek Wealth Advisors LLC Has $1.25 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Turtle Creek Wealth Advisors LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 13.7% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,139 shares of the healthcare conglomerate’s stock after purchasing an additional 258 shares during the quarter. Turtle Creek Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $1,251,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Delta Financial Group Inc. increased its holdings in shares of UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after purchasing an additional 17 shares in the last quarter. Signature Resources Capital Management LLC boosted its holdings in UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares during the last quarter. Saxony Capital Management LLC raised its stake in shares of UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after buying an additional 18 shares during the last quarter. GoalVest Advisory LLC grew its holdings in UnitedHealth Group by 0.6% during the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after acquiring an additional 18 shares during the period. Finally, Fiduciary Group LLC increased its stake in shares of UnitedHealth Group by 0.5% in the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after acquiring an additional 18 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. TD Cowen increased their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Stephens cut their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Truist Financial reaffirmed a “buy” rating and issued a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. KeyCorp initiated coverage on UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective for the company. Finally, Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Three investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Stock Performance

Shares of UNH traded down $0.92 during mid-day trading on Friday, hitting $592.23. 3,423,919 shares of the company’s stock were exchanged, compared to its average volume of 3,888,996. The firm has a market cap of $545.02 billion, a price-to-earnings ratio of 38.58, a price-to-earnings-growth ratio of 1.78 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock’s 50-day simple moving average is $582.84 and its 200-day simple moving average is $549.06.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the prior year, the company posted $6.56 earnings per share. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s payout ratio is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.